by Aleksandar Nikolajevic | Sep 29, 2024 | Newsletter
September 2024 Newsletter Summary: Mpox Clade Ib typing now available in addition to DNA detection Free PCR laboratory testing for cases with justified suspicion and official notification Clinical criteria include non-specific symptoms, maculopapular rash, and...
by Aleksandar Nikolajevic | Aug 29, 2024 | Newsletter
August 2024 Newsletter Summary: Global increase: WHO reports 7.6 million Dengue cases by April 2024 – significant rise also in Austria with 65 cases in the first quarter of 2024 Symptoms and progression: 75% of infections asymptomatic; symptomatic cases present...
by Aleksandar Nikolajevic | Mar 29, 2025 | Newsletter
March 2025 Newsletter Summary: Tick season starts earlier and lasts longer due to climate change – increased risk for TBE, Lyme disease, and HGE Lyme disease progresses in three stages, with erythema migrans appearing as the first symptom in 70-80% of cases...
by Aleksandar Nikolajevic | Jul 29, 2025 | Newsletter
July 2025 Newsletter Summary: The Chikungunya virus is increasingly spreading to Central Europe via the Asian tiger mosquito – first autochthonous case reported in the Alsace region Key symptoms include high fever and severe joint and muscle pain; up to 50% of...
by Aleksandar Nikolajevic | Sep 29, 2025 | Newsletter
September 2025 Newsletter Summary: RSV is the most common reason for hospitalizations among infants and young children in Austria – over 2,600 children aged 0 to 4 were hospitalized in the 2023/2024 season The monoclonal antibody Nirsevimab (Beyfortus) was...
